Cite

HARVARD Citation

    Lal, C. et al. (2019). Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert opinion on pharmacotherapy. pp. 1075-1085. [Online]. 
  
Back to record